relapsing or primary progressive multiple sclerosis (RMS or PPMS)

• Business
• Education
• Healthcare
• Industrial
• Management
• News
• Pharma & Biotech
• Science
• Switzerland
• Technology

Roche’s OCREVUS Subcutaneous Injection Shows Promise in Phase III Study for Multiple Sclerosis Treatment

(IN BRIEF) Roche has announced positive late-breaking data from the Phase III OCARINA II study, which demonstrates the effectiveness of…